Paper Details

  1. Home
  2. Paper Details

Ab interno trabecular bypass surgery with Schlemm´s canal microstent (Hydrus) for open angle glaucoma.

Author: BunceCatey, GazzardGus, HuKuang, OtarolaFrancisco, ShahAnupa, VirgiliGianni

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Adding the Hydrus microstent to cataract surgery in people with cataracts and mild to moderate open angle glaucoma likely increases the proportion of participants who do not require IOP lowering medication and may further reduce IOP at short- and medium-term follow-up.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Glaucoma is a leading cause of irreversible blindness. A number of minimally-invasive surgical techniques have been introduced as a treatment to prevent glaucoma from progressing; ab interno trabecular bypass surgery with the Schlemm's canal Hydrus microstent is one of them. OBJECTIVES:...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061024/

データ提供：米国国立医学図書館（NLM）

A New Path for Glaucoma Treatment: The Hydrus Microstent

Glaucoma, a leading cause of irreversible blindness, presents a significant challenge for ophthalmologists. This research evaluates the efficacy and safety of ab interno trabecular bypass surgery with the Hydrus microstent, a minimally invasive surgical technique for treating open-angle glaucoma (OAG). The researchers conducted a systematic review of randomized controlled trials (RCTs) to assess the effectiveness of this novel surgical approach.

The Hydrus Microstent: A Promising New Option for Glaucoma Management

The review revealed that the Hydrus microstent, when combined with cataract surgery, may increase the proportion of patients who become medication-free for glaucoma. It also suggests that the Hydrus microstent may be more effective than the iStent in lowering intraocular pressure (IOP) in patients with OAG. These findings highlight the potential of the Hydrus microstent as a promising new option for managing OAG and preventing vision loss.

A Glimpse into the Future of Glaucoma Treatment

The research on the Hydrus microstent represents a significant step forward in the field of glaucoma treatment. This minimally invasive surgical technique offers a potential alternative to traditional surgical interventions, potentially improving patient outcomes and reducing the need for medications. It's a reminder that innovation and advancements in medical technology can lead to new and effective ways to address challenging health conditions.

Dr.Camel's Conclusion

This review highlights the potential of the Hydrus microstent as a promising new approach for treating open-angle glaucoma. The research suggests that this minimally invasive surgical technique may offer a more effective and less invasive option for managing glaucoma, potentially reducing the need for medications and improving patient outcomes. It's a glimpse into the future of glaucoma treatment, where innovation and advancements in technology are leading to new pathways for preventing vision loss and preserving sight.

Date :
  1. Date Completed 2020-08-26
  2. Date Revised 2021-12-07
Further Info :

Pubmed ID

32147807

DOI: Digital Object Identifier

PMC7061024

Related Literature

Article Analysis
・Effective treatment of glaucoma
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.